- •Hematuria II: causes and investigation
- •Hematospermia
- •Lower urinary tract symptoms (LUTS)
- •Nocturia and nocturnal polyuria
- •Flank pain
- •Urinary incontinence in adults
- •Genital symptoms
- •Abdominal examination in urological disease
- •Digital rectal examination (DRE)
- •Lumps in the groin
- •Lumps in the scrotum
- •2 Urological investigations
- •Urine examination
- •Urine cytology
- •Radiological imaging of the urinary tract
- •Uses of plain abdominal radiography (KUB X-ray—kidneys, ureters, bladder)
- •Intravenous pyelography (IVP)
- •Other urological contrast studies
- •Computed tomography (CT) and magnetic resonance imaging (MRI)
- •Radioisotope imaging
- •Post-void residual urine volume measurement
- •3 Bladder outlet obstruction
- •Regulation of prostate growth and development of benign prostatic hyperplasia (BPH)
- •Pathophysiology and causes of bladder outlet obstruction (BOO) and BPH
- •Benign prostatic obstruction (BPO): symptoms and signs
- •Diagnostic tests in men with LUTS thought to be due to BPH
- •Why do men seek treatment for their symptoms?
- •Watchful waiting for uncomplicated BPH
- •Medical management of BPH: combination therapy
- •Medical management of BPH: alternative drug therapy
- •Minimally invasive management of BPH: surgical alternatives to TURP
- •Invasive surgical alternatives to TURP
- •TURP and open prostatectomy
- •Indications for and technique of urethral catheterization
- •Indications for and technique of suprapubic catheterization
- •Management of nocturia and nocturnal polyuria
- •High-pressure chronic retention (HPCR)
- •Bladder outlet obstruction and retention in women
- •Urethral stricture disease
- •4 Incontinence
- •Causes and pathophysiology
- •Evaluation
- •Treatment of sphincter weakness incontinence: injection therapy
- •Treatment of sphincter weakness incontinence: retropubic suspension
- •Treatment of sphincter weakness incontinence: pubovaginal slings
- •Overactive bladder: conventional treatment
- •Overactive bladder: options for failed conventional therapy
- •“Mixed” incontinence
- •Post-prostatectomy incontinence
- •Incontinence in the elderly patient
- •Urinary tract infection: microbiology
- •Lower urinary tract infection
- •Recurrent urinary tract infection
- •Urinary tract infection: treatment
- •Acute pyelonephritis
- •Pyonephrosis and perinephric abscess
- •Other forms of pyelonephritis
- •Chronic pyelonephritis
- •Septicemia and urosepsis
- •Fournier gangrene
- •Epididymitis and orchitis
- •Periurethral abscess
- •Prostatitis: presentation, evaluation, and treatment
- •Other prostate infections
- •Interstitial cystitis
- •Tuberculosis
- •Parasitic infections
- •HIV in urological surgery
- •6 Urological neoplasia
- •Pathology and molecular biology
- •Prostate cancer: epidemiology and etiology
- •Prostate cancer: incidence, prevalence, and mortality
- •Prostate cancer pathology: premalignant lesions
- •Counseling before prostate cancer screening
- •Prostate cancer: clinical presentation
- •PSA and prostate cancer
- •PSA derivatives: free-to-total ratio, density, and velocity
- •Prostate cancer: transrectal ultrasonography and biopsies
- •Prostate cancer staging
- •Prostate cancer grading
- •General principles of management of localized prostate cancer
- •Management of localized prostate cancer: watchful waiting and active surveillance
- •Management of localized prostate cancer: radical prostatectomy
- •Postoperative course after radical prostatectomy
- •Prostate cancer control with radical prostatectomy
- •Management of localized prostate cancer: radical external beam radiotherapy (EBRT)
- •Management of localized prostate cancer: brachytherapy (BT)
- •Management of localized and radiorecurrent prostate cancer: cryotherapy and HIFU
- •Management of locally advanced nonmetastatic prostate cancer (T3–4 N0M0)
- •Management of advanced prostate cancer: hormone therapy I
- •Management of advanced prostate cancer: hormone therapy II
- •Management of advanced prostate cancer: hormone therapy III
- •Management of advanced prostate cancer: androgen-independent/ castration-resistant disease
- •Palliative management of prostate cancer
- •Prostate cancer: prevention; complementary and alternative therapies
- •Bladder cancer: epidemiology and etiology
- •Bladder cancer: pathology and staging
- •Bladder cancer: presentation
- •Bladder cancer: diagnosis and staging
- •Muscle-invasive bladder cancer: surgical management of localized (pT2/3a) disease
- •Muscle-invasive bladder cancer: radical and palliative radiotherapy
- •Muscle-invasive bladder cancer: management of locally advanced and metastatic disease
- •Bladder cancer: urinary diversion after cystectomy
- •Transitional cell carcinoma (UC) of the renal pelvis and ureter
- •Radiological assessment of renal masses
- •Benign renal masses
- •Renal cell carcinoma: epidemiology and etiology
- •Renal cell carcinoma: pathology, staging, and prognosis
- •Renal cell carcinoma: presentation and investigations
- •Renal cell carcinoma: active surveillance
- •Renal cell carcinoma: surgical treatment I
- •Renal cell carcinoma: surgical treatment II
- •Renal cell carcinoma: management of metastatic disease
- •Testicular cancer: epidemiology and etiology
- •Testicular cancer: clinical presentation
- •Testicular cancer: serum markers
- •Testicular cancer: pathology and staging
- •Testicular cancer: prognostic staging system for metastatic germ cell cancer
- •Testicular cancer: management of non-seminomatous germ cell tumors (NSGCT)
- •Testicular cancer: management of seminoma, IGCN, and lymphoma
- •Penile neoplasia: benign, viral-related, and premalignant lesions
- •Penile cancer: epidemiology, risk factors, and pathology
- •Squamous cell carcinoma of the penis: clinical management
- •Carcinoma of the scrotum
- •Tumors of the testicular adnexa
- •Urethral cancer
- •Wilms tumor and neuroblastoma
- •7 Miscellaneous urological diseases of the kidney
- •Cystic renal disease: simple cysts
- •Cystic renal disease: calyceal diverticulum
- •Cystic renal disease: medullary sponge kidney (MSK)
- •Acquired renal cystic disease (ARCD)
- •Autosomal dominant (adult) polycystic kidney disease (ADPKD)
- •Ureteropelvic junction (UPJ) obstruction in adults
- •Anomalies of renal ascent and fusion: horseshoe kidney, pelvic kidney, malrotation
- •Renal duplications
- •8 Stone disease
- •Kidney stones: epidemiology
- •Kidney stones: types and predisposing factors
- •Kidney stones: mechanisms of formation
- •Evaluation of the stone former
- •Kidney stones: presentation and diagnosis
- •Kidney stone treatment options: watchful waiting
- •Stone fragmentation techniques: extracorporeal lithotripsy (ESWL)
- •Intracorporeal techniques of stone fragmentation (fragmentation within the body)
- •Kidney stone treatment: percutaneous nephrolithotomy (PCNL)
- •Kidney stones: open stone surgery
- •Kidney stones: medical therapy (dissolution therapy)
- •Ureteric stones: presentation
- •Ureteric stones: diagnostic radiological imaging
- •Ureteric stones: acute management
- •Ureteric stones: indications for intervention to relieve obstruction and/or remove the stone
- •Ureteric stone treatment
- •Treatment options for ureteric stones
- •Prevention of calcium oxalate stone formation
- •Bladder stones
- •Management of ureteric stones in pregnancy
- •Hydronephrosis
- •Management of ureteric strictures (other than UPJ obstruction)
- •Pathophysiology of urinary tract obstruction
- •Ureter innervation
- •10 Trauma to the urinary tract and other urological emergencies
- •Renal trauma: clinical and radiological assessment
- •Renal trauma: treatment
- •Ureteral injuries: mechanisms and diagnosis
- •Ureteral injuries: management
- •Bladder and urethral injuries associated with pelvic fractures
- •Bladder injuries
- •Posterior urethral injuries in males and urethral injuries in females
- •Anterior urethral injuries
- •Testicular injuries
- •Penile injuries
- •Torsion of the testis and testicular appendages
- •Paraphimosis
- •Malignant ureteral obstruction
- •Spinal cord and cauda equina compression
- •11 Infertility
- •Male reproductive physiology
- •Etiology and evaluation of male infertility
- •Lab investigation of male infertility
- •Oligospermia and azoospermia
- •Varicocele
- •Treatment options for male factor infertility
- •12 Disorders of erectile function, ejaculation, and seminal vesicles
- •Physiology of erection and ejaculation
- •Impotence: evaluation
- •Impotence: treatment
- •Retrograde ejaculation
- •Peyronie’s disease
- •Priapism
- •13 Neuropathic bladder
- •Innervation of the lower urinary tract (LUT)
- •Physiology of urine storage and micturition
- •Bladder and sphincter behavior in the patient with neurological disease
- •The neuropathic lower urinary tract: clinical consequences of storage and emptying problems
- •Bladder management techniques for the neuropathic patient
- •Catheters and sheaths and the neuropathic patient
- •Management of incontinence in the neuropathic patient
- •Management of recurrent urinary tract infections (UTIs) in the neuropathic patient
- •Management of hydronephrosis in the neuropathic patient
- •Bladder dysfunction in multiple sclerosis, in Parkinson disease, after stroke, and in other neurological disease
- •Neuromodulation in lower urinary tract dysfunction
- •14 Urological problems in pregnancy
- •Physiological and anatomical changes in the urinary tract
- •Urinary tract infection (UTI)
- •Hydronephrosis
- •15 Pediatric urology
- •Embryology: urinary tract
- •Undescended testes
- •Urinary tract infection (UTI)
- •Ectopic ureter
- •Ureterocele
- •Ureteropelvic junction (UPJ) obstruction
- •Hypospadias
- •Normal sexual differentiation
- •Abnormal sexual differentiation
- •Cystic kidney disease
- •Exstrophy
- •Epispadias
- •Posterior urethral valves
- •Non-neurogenic voiding dysfunction
- •Nocturnal enuresis
- •16 Urological surgery and equipment
- •Preparation of the patient for urological surgery
- •Antibiotic prophylaxis in urological surgery
- •Complications of surgery in general: DVT and PE
- •Fluid balance and management of shock in the surgical patient
- •Patient safety in the operating room
- •Transurethral resection (TUR) syndrome
- •Catheters and drains in urological surgery
- •Guide wires
- •JJ stents
- •Lasers in urological surgery
- •Diathermy
- •Sterilization of urological equipment
- •Telescopes and light sources in urological endoscopy
- •Consent: general principles
- •Cystoscopy
- •Transurethral resection of the prostate (TURP)
- •Transurethral resection of bladder tumor (TURBT)
- •Optical urethrotomy
- •Circumcision
- •Hydrocele and epididymal cyst removal
- •Nesbit procedure
- •Vasectomy and vasovasostomy
- •Orchiectomy
- •Urological incisions
- •JJ stent insertion
- •Nephrectomy and nephroureterectomy
- •Radical prostatectomy
- •Radical cystectomy
- •Ileal conduit
- •Percutaneous nephrolithotomy (PCNL)
- •Ureteroscopes and ureteroscopy
- •Pyeloplasty
- •Laparoscopic surgery
- •Endoscopic cystolitholapaxy and (open) cystolithotomy
- •Scrotal exploration for torsion and orchiopexy
- •17 Basic science of relevance to urological practice
- •Physiology of bladder and urethra
- •Renal anatomy: renal blood flow and renal function
- •Renal physiology: regulation of water balance
- •Renal physiology: regulation of sodium and potassium excretion
- •Renal physiology: acid–base balance
- •18 Urological eponyms
- •Index
160 CHAPTER 5 Infections and inflammatory conditions
Fournier gangrene
Fournier gangrene is a necrotizing fasciitis of the genitalia and perineum primarily affecting males and causing necrosis and subsequent gangrene of infected tissues. Culture of infected tissue reveals a mixed polymicrobial infection with aerobic (E. coli, enterococcus, Klebsiella) and anaerobic organisms (Bacteroides, Clostridium, microaerophilic streptococci), which are believed to grow in a synergistic fashion.
Conditions predisposing to the development of Fournier gangrene include diabetes, local trauma to the genitalia and perineum (e.g., zipper injuries to the foreskin, periurethral extravasation of urine following traumatic catheterization or instrumentation of the urethra), and surgical procedures such as circumcision.
Presentation
This is one of the most dramatic and rapidly progressing infections in medicine. A previously well patient may become critically ill over a very short time course (hours). It may follow a seemingly trivial injury to the external genitalia.
A fever is usually present, the patient looks very ill, with marked pain in the affected tissues, and the developing sepsis may alter the patient’s mental state. The genitalia and perineum are edematous, and on palpation of the affected area, tenderness and crepitus may be present, indicating presence of subcutaneous gas produced by gas-forming organisms.
As the infection advances, blisters (bullae) appear in the skin and, within a matter of hours, areas of necrosis may develop on the genitalia and perineum that spread to involve adjacent tissues (e.g., the lower abdominal wall).
The condition advances rapidly—hence its alternative name of spontaneous fulminant gangrene of the genitalia.
Diagnosis
The diagnosis is a clinical one and is based on awareness of the condition and a high index of suspicion. CT will demonstrate areas of subcutaneous areas of necrosis and gas.
Treatment
Do not delay. While IV access is obtained, blood taken for culture, IV fluids started, and oxygen administered, broad-spectrum antibiotics are given to cover both gram-positive and gram-negative aerobes and anaerobes (e.g., ampicillin, gentamicin, and metronidazole or clindamycin). Monitor for signs of septic shock and manage as noted on p. 156.
Make arrangements to transfer the patient to the operating room emergently so that debridement of necrotic tissue (skin, subcutaneous fat) can be carried out. Extensive areas of tissue may have to be removed, but it is unusual for the testes or deeper penile tissues to be involved, and these can usually be spared.
A suprapubic catheter is inserted to divert urine and allow monitoring of urine output.
FOURNIER GANGRENE 161
Where facilities allow, consider treatment with hyperbaric oxygen therapy.1 There is some evidence that this may be beneficial. Repeated débridements to remove residual necrotic tissue are usually required with subsequent skin grafting required.
A VAC (vacuum-assisted closure) dressing can be used or wet-to- dry dressing changes are performed 2–3 times a day. Repeat operative debridement every 24–72 hours may be necessary to remove newly necrotic tissue.
Mortality is on the order of 20–30%. There is debate about whether diabetes increases the mortality rate.
Further reading
Chawla SN, Gallop C, Mydlo JH (2003). Fournier’s gangrene: an analysis of repeated surgical debridement. Eur Urol 43:572–575.
Sorensen MD, Broghammer JA, Rivara FP, et al. (2008). Fournier’s gangrene—contemporary popu- lation-based incidence and outcomes analysis: a HCUP database study. J Urol 179(4):13.
1 Mindrup SR, Kealey GP, Fallon B (2005). Hyperbaric oxygen for the treatment of Fournier’s gangrene. J Urol 173:1975–1977.
162 CHAPTER 5 Infections and inflammatory conditions
Epididymitis and orchitis
This is an inflammatory condition of the epididymis, often involving the testis, and caused usually caused by bacterial infection. It has an acute onset and a clinical course lasting <6 weeks. It presents with pain, swelling, and tenderness of the epididymis.
It should be distinguished from chronic epididymitis, where there is longstanding pain in the epididymis but usually no swelling. Untreated, bacterial epididymitis can extend to the testicle, resulting in epididmo-orchitis.
Infection ascends from the urethra or bladder. In men aged <35 years, the infective organism is usually N. gonorrhoeae, C. trachomatis, or coliform bacteria (causing a urethritis that then ascends to infect the epididymis).
In children and older men, the infective organisms are usually coliforms (such as E coli, Pseudomonas, Proteus, and Klebsiella species). Occasionally, Ureaplasma urealyticum, Corynebacterium, or Mycoplasma is the cause.
Mycobacterium tuberculosis (TB) is a rarer cause—the epididymis feels like a beaded cord.
A rare, noninfective cause of epididymitis is the antiarrhythmic drug amiodarone, which causes inflammation and resolves on discontinuation of the drug. Vasculitis, sarcoidosis, and more rare infections (coccidioidomycosis, blastomycosis) can be seen in immunocompromised men.
Differential diagnosis
Torsion of the testicle is the leading differential diagnosis. A preceding history of symptoms suggestive of urethritis, STD or urinary infection (dysuria, frequency, urgency, and suprapubic pain) suggest that epididymitis is the cause of the scrotal pain, but these symptoms may not always be present in epididymitis.
In epididymitis pain, tenderness and swelling may be confined to the epididymis, whereas in torsion, the pain and swelling are localized to the testis. However, there may be overlap in these physical signs.
Where the diagnosis is not clear between torsion or epididymitis, exploration is the safest option. Though radionuclide scanning can differentiate between a torsion and epididymitis, this is not available in many hospitals.
Color Doppler ultrasonography, which provides a visual image of blood flow, can differentiate between a torsion and epididymitis, but its sensitivity for diagnosing torsion is only 80% (i.e., it ‘misses’ the diagnosis in as many as 20% of cases—these 20% have torsion but normal findings on Doppler ultrasonography of the testis). Its sensitivity for diagnosing epididymitis is about 70%.
Again, if in doubt, explore. Complications of acute epididymitis abscess formation, infarction of the testis, chronic pain, and infertility.
Treatment of epididymitis
Culture urine, any urethral discharge, and blood (if the patient appears systemically ill). Urine cultures are often sterile. Management consists of bed rest, analgesia, anti-inflammatories, ice packs and antibiotics. Any form of urethral instrumentation should be avoided.
EPIDIDYMITIS AND ORCHITIS 163
•With suspected gonorrhea infection: Ceftriaxone 125 mg IM in a single dose or Cefixime 400 mg orally in a single dose or 400 mg by suspension (200 mg/5 mL) with treatment for chlamydia if chlamydial infection is not ruled out.
•Where C. trachomatis is a possible infecting organism, prescribe a 10–14 day course of tetracycline 500 mg 4 times a day or doxycycline 100mg twice daily.
•For non-STD related epididymitis, prescribe antibiotics empirically (until culture results are available). Typically levofloxin or ofloxacin x 14 days.
•When the patient is systemically ill, IV gentamicin and ampicillin are often used. When afebrile complete a 14 day total antibiotic course based on sensitivities.
Chronic epididymitis
Chronic epididymitis is diagnosed in patients with long-term pain in the epididymis and testicle. It can result from recurrent episodes of acute epididymitis. Clinically, the epididymis is thickened and may be tender. Treatment is with the appropriate antibiotics (guided by cultures), or epididymectomy in severe cases.
Supportive therapy with gabapentin and tricyclic antidepressants has shown to sometimes control symptoms.
Orchitis
Orchitis is inflammation of the testis, although it often occurs with epididymitis (epididymo-orchitis). Causes include mumps; M. tuberculosis; syphilis; autoimmune processes (granulomatous orchitis). The testis is swollen and tense, with edema of connective tissues and inflammatory cell infiltration. Treat the underlying cause.
Mumps orchitis occurs in 30% of infected post-pubertal males. It manifests 3–4 days after the onset of parotitis, and can result in tubular atrophy. 10–30% of cases are bilateral and are associated with infertility.